{"nct_id":"NCT04383938","title":"Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies","status":"COMPLETED","status_verified_date":"2025-05","start_date":"2020-06-25","start_date_type":"ACTUAL","primary_completion_date":"2022-04-30","primary_completion_date_type":"ACTUAL","completion_date":"2022-04-30","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["APRE"]}